These results demonstrate that Cisd2 is a haploinsufficient tumor-suppressor gene in the mouse liver and that increased expression of Cisd2 is able to attenuate hepatocarcinogenesis and suppress HCC development [20,21]. This evidence concerns the gene CISD2 and neoplasm.